Are drug prices turning what's being called the golden age of science into the gilded age in the U.S.? That's the question Sen. Tim Kaine (D-Va.) posed Tuesday as the Senate Health, Education, Labor and Pensions (HELP) Committee held its third hearing on high drug prices.